Stem Cell Technology: Novel Treatment Shows Promise For Nonhealing Digital Ulcers
Saturday, 05 September 2009 11:11
Ilya Petrou, M.D.
Published: Sep 1, 2009
Source: http://www.modernmedicine.com/modernmedicine/Modern+Medicine+Now/Stem-cell-technology-Novel-treatment-shows-promise/ArticleStandard/Article/detail/622608?ref=25

Introduction:
Stem cells have been used for the treatment of difficult-to-heal cutaneous wounds, such as diabetic and venous leg ulcers, as well as large defects following skin cancer surgery. Recent research has shown that this therapeutic approach not only can help close other cutaneous wounds, but it can do so quickly, bringing much-needed relief to these patients.

"After achieving very positive results in leg ulcers by using stem cell technology, we applied this approach with the addition of bioengineered skin to the digital ulcers seen in systemic sclerosis (scleroderma) patients and managed to close the wounds within two weeks.

"For cutaneous wounds that are difficult to heal, the use of stem cells combined with bioengineered skin appears to be a promising therapeutic option, as wounds' closure speed is dramatic," says Vincent Falanga, M.D., F.A.C.P., professor of dermatology and biochemistry at Boston University, Boston, and chairman of the department of dermatology and skin surgery at Roger Williams Medical Center in Providence, R.I. He is also the principal investigator of a recently renewed National Institutes of Health Center of Biomedical Research Excellence at the medical center, totally focused on tissue repair and stem cells.

Continue Reading here:
 
More articles :

» L-selectin and Skin Damage in Systemic Sclerosis

L-selectin ligands are induced on the endothelium of inflammatory sites. L-selectin expression on neutrophils and monocytes may mediate the primary adhesion of these cells at sites of inflammation by mediating the leukocyte-leukocyte interactions...

» Platelet Gel In The Treatment Of Severe Scleroderma Skin Ulcers

Dilia Giuggioli, Michele Colaci, Andreina Manfredi, Mariateresa Mariano and Clodoveo FerriSystemic sclerosis (SSc) is characterized by microvascular damage and fibrosis of the skin and internal organs. Non-healing skin ulcers, mainly non-venous leg...

» Lower Extremity Ulcers in Systemic Sclerosis: Features and Response to Therapy

Victoria K. Shanmugam, MBBS, MRCP; Patricia Price, PhD; Christopher E. Attinger, MD; Virginia D. Steen, MD Non-digital lower extremity ulcers are a difficult to treat complication of scleroderma that is often refractory to therapy. They are a...

» Central Nervous System Manifestations In Scleroderma

We at the believe that knowledge is indeed, power. It was this belief that became the primary motivation for the creation of our website. It was meant to empower all patients to take control of the disease through news and informative articles, and...

» The Role of Intravenous Immunoglobulin Preparations in the Treatment of Systemic Sclerosis

Marta Baleva and Krasimir NikolovReceived 12 June 2011; Revised 28 August 2011; Accepted 28 August 2011Scleroderma is progressive autoimmune disease associated with severe disability. The major underlying pathological process in scleroderma is...

» Unite Against Scleroderma 2012

For our second year running, the Scleroderma Care Foundation will be hosting its “Unite Against Scleroderma” Awareness Walk around the , Port of Spain. Scheduled to start from 3:00pm, the Walk would be held on Sunday May 6th 2012 and cover one...